Curaleaf Holdings CEO Joseph Lusardi is ecstatic about the company’s record-setting, $400 million USD equity raise and recent listing on the CSE. Curaleaf operates in the United States, is a fully vertical medical cannabis operator, and sells 90 percent of what the company cultivates and produces in its dispensaries. The company will be operating in 12 states by the end of 2018 and is licensed to open 69 dispensaries nation-wide. Curaleaf’s largest footprint is in Florida, where it already has a strong delivery presence and 13 dispensaries, with plans to open 22 more stores in the coming months. Lusardi supports the STATES Act because it would open up banking and debt markets to US cannabis companies.
Related Articles → See More
-
“Growing great plants is only half the battle, keeping their natural power intact is what matters”
-
"Indoor crops could be key for future food security"
-
China works to minimize flood impact, ensure vegetable supply
-
Heart Research Institute looks at ways vegetables could treat strokes
-
CAN: Companies seek approval for C-19 vaccine, using plants to express proteins needed
-
Spain approves hiring 80,000 unemployed and immigrants to cover farm shortfall
-
HortiDaily starts MMJDaily.com
-
Aphria shows automation in new video
-
CEA Advisors forms new division focused on cannabis industry
-
Denmark: Spectrum Cannabis ready for sale in autumn